Literature DB >> 19920662

Trabeculectomy with mitomycin C for normal-tension glaucoma.

T Yamamoto1, M Ichien, H Suemori-Matsushita, Y Kitazawa.   

Abstract

PURPOSE: A prospective investigation of the postoperative intraocular pressure level, visual function changes, and postoperative complications of trabeculectomy with adjunctive mitomycin C in normal-tension glaucoma. PATIENTS AND METHODS: Thirty-one patients (31 eyes) who underwent trabeculectomy with 0.4 mg/ml mitomycin C were studied. The preoperative intraocular pressure of the eyes ranged from 11 to 18 mm Hg with a mean (+/- SD) of 14.1 +/- 1.9 mm Hg. Follow-up examinations were performed at least once a month for 14-35 months (mean: 24.4 months).
RESULTS: Intraocular pressures decreased to between 4 and 14 mm Hg with a mean (+/- SD) of 8.4 +/- 2.4 mm Hg at the last three follow-up visits. The magnitude of the intraocular pressure reduction ranged from 1 to 10 mm Hg, with a mean of 5.8 mm Hg. Final measurements of postoperative intraocular pressure ranged between 5 and 12 mm Hg in 27 eyes (87%). Visual acuity deteriorated two lines or more in seven eyes, which was caused by cataract. The visual field deteriorated postoperatively in two eyes (6%): their respective postoperative intraocular pressures averaged 9.4 and 7.5 mm Hg. Hypotonous maculopathy developed in three eyes (10%).
CONCLUSIONS: Trabeculectomy with mitomycin C appears to have potential as a treatment modality of choice for normal-tension glaucoma, because a large majority of the patients in the present study achieved an intraocular pressure allegedly beneficial in managing normal-tension glaucoma.

Entities:  

Year:  1995        PMID: 19920662

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  3 in total

1.  Safety And Efficacy Of Achieving Single-Digit Intraocular Pressure Targets With Filtration Surgery In Eyes With Progressive Normal-Tension Glaucoma.

Authors:  Scott K Schultz; Shawn M Iverson; Wei Shi; David S Greenfield
Journal:  J Glaucoma       Date:  2016-02       Impact factor: 2.503

2.  Trabeculectomy With Antimetabolite Agents for Normal Tension Glaucoma: A Systematic Review and Meta-Analysis.

Authors:  Chin Lai; Shih-Chieh Shao; Yi-Hung Chen; Yu-Kai Kuo; Chi-Chun Lai; Lan-Hsin Chuang
Journal:  Front Med (Lausanne)       Date:  2022-06-28

3.  The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery.

Authors:  Kotaro Yamamoto; Taiki Kokubun; Kota Sato; Takahiro Akaishi; Atsushi Shimazaki; Masatsugu Nakamura; Yukihiro Shiga; Satoru Tsuda; Kazuko Omodaka; Hideyuki Saya; Toru Nakazawa
Journal:  Sci Rep       Date:  2019-12-17       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.